Welcome to our dedicated page for Vsee Health news (Ticker: VSEEW), a resource for investors and traders seeking the latest updates and insights on Vsee Health stock.
VSee Health, Inc. (Nasdaq: VSEE, VSEEW) is a telehealth technology and services company that reports on developments in telehealth, remote patient monitoring, and digital health services. Its public communications describe a scalable, API-driven platform that integrates secure video, device data, and EHR connectivity to support hospital systems, health networks, and employers across the United States.
The news flow for VSee Health can include corporate updates related to its Nasdaq listing status and capital structure. For example, the company has announced that it regained compliance with Nasdaq Listing Rule 5550(b)(1), the Minimum Equity Rule, after previously receiving notice that its stockholders’ equity was below the required threshold. In that context, it disclosed capital transactions such as conversion of convertible notes into common stock, cash exercise and exchange of certain public warrants, and a private placement of common stock or pre-funded warrants with accompanying warrants.
Readers following VSee Health news can expect disclosures about its telehealth platform, digital health services, and financial or regulatory milestones that affect its operations and listing on The Nasdaq Capital Market. Company announcements may also reference filings with the Securities and Exchange Commission, such as a pro forma balance sheet filed on Form 8-K/A in connection with its equity compliance.
This news page aggregates such company-issued updates and related coverage, helping users review how VSee Health communicates its progress in telehealth, remote patient monitoring, and digital health services, as well as material events tied to its capital structure and exchange listing.
VSee Health (Nasdaq:VSEE, VSEEW) announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1) after its stockholders' equity rose to approximately $9.5 million pro forma as of December 1, 2025. The company attributes the increase to: full conversion of multiple convertible notes into common stock; cash exercise and exchange of certain public warrants; and a $6.0 million private placement (or pre-funded warrants) with accompanying warrants completed on November 25, 2025. A pro forma balance sheet was filed on Form 8-K/A on December 11, 2025. The company said the transactions reduced debt and derivative liabilities and provided additional working capital for its telehealth and digital health operations.